MANILA, April 5 (Reuters): Drugmaker Johnson & Johnson has filed its application for emergency use authorisation of its Covid-19 vaccine in the Philippines, the country's Food and Drug Administration (FDA) chief said on Monday.
J&J's documents, which were submitted on Wednesday, are now under evaluation, FDA Director General Rolando Enrique Domingo told reporters.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!